Abstract

Background: Diagnostic methods for the early identification of ovarian cancer (OC) represent an unmet clinical need, as no reliable diagnostic tools are available. Here, we tested the feasibility of electronic nose (e-nose), composed of ten metal oxide semiconductor (MOS) sensors, as a diagnostic tool for OC detection. Methods: Women with suspected ovarian masses and healthy subjects had volatile organic compounds analysis of the exhaled breath using e-nose. Results: E-nose analysis was performed on breath samples collected from 251 women divided into three groups: 86 OC cases, 51 benign masses, and 114 controls. Data collected were analyzed by Principal Component Analysis (PCA) and K-Nearest Neighbors’ algorithm (K-NN). A first 1-K-NN (cases vs. controls) model has been developed to discriminate between OC cases and controls; the model performance tested in the prediction gave 98% of sensitivity and 95% of specificity, when the strict class prediction was applied; a second 1-K-NN (cases vs. controls + benign) model was built by grouping the non-cancer groups (controls + benign), thus considering two classes, cases and controls + benign; the model performance in the prediction was of 89% for sensitivity and 86% for specificity when the strict class prediction was applied. Conclusions: Our preliminary results suggested the potential role of e-nose for the detection of OC. Further studies aiming to test the potential adoption of e-nose in the early diagnosis of OC are needed.

Highlights

  • It is estimated that over 22,000 new cases of ovarian cancer (OC) will be diagnosed and that 14,000 women will die of this disease in 2020 only in the U.S OC is the fifth most common cancer in women and the most common cause of gynecologic cancer deaths, being one of the most lethal cancers in women [1]

  • The study population was divided into three main groups: (1) controls—healthy subjects without adnexal masses (114 patients; 45.4%); (2) OC cases—women with malignant adnexal masses (86 patients; 34.3%); (3)

  • The present study investigated the role of e-nose as a diagnostic tool for the detection of OC, reporting several noteworthy findings

Read more

Summary

Introduction

It is estimated that over 22,000 new cases of ovarian cancer (OC) will be diagnosed and that 14,000 women will die of this disease in 2020 only in the U.S OC is the fifth most common cancer in women and the most common cause of gynecologic cancer deaths, being one of the most lethal cancers in women [1]. To date, no screening test is accurate and reliable enough to detect OC in women. Diagnostic methods for the early identification of ovarian cancer (OC). Represent an unmet clinical need, as no reliable diagnostic tools are available. Methods: Women with suspected ovarian masses and healthy subjects had volatile organic compounds analysis of the exhaled breath using e-nose. Results: E-nose analysis was performed on breath samples collected from 251 women divided into three groups: 86 OC cases, 51 benign masses, and 114 controls. Conclusions: Our preliminary results suggested the potential role of e-nose for the detection of OC. Further studies aiming to test the potential adoption of e-nose in the early diagnosis of OC are needed

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.